Journey Medical Corporation (NASDAQ: DERM) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $110M. The Maz Rating grades it against the other companies in its sector.
Journey Medical Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $3.90, Journey Medical Corporation trades at 1.5x sales and 3.1x book value, with an EV/EBITDA of 40.4. Over the last twelve months it generated about $75M of revenue and a net loss of $6M. It runs a gross margin of 43.2%, an operating margin of -2.9% and a net margin of -7.3%. It shows return on equity of -16.1%, return on invested capital of -3.5% and a free cash flow yield of -8.0%. On the balance sheet: a debt-to-equity ratio of 0.79 and a current ratio of 1.48. Over the past 52 weeks the share price ranged from $3.40 to $9.56, with a beta of 1.15.
Journey Medical Corporation does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 3 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.